A condition affecting up to 80% of U.S. women, uterine fibroids remain under-funded, under-researched, and under-discussed despite causing severe health and economic burdens.
In the United States, fibroids affect an estimated 70% to 80% of women, often causing heavy bleeding, pain, bloating, and fertility problems, and they are the primary reason for hysterectomies.
Federal funding for fibroid research totals about $17 million annually, ranking the condition near the bottom of NIH priorities, while the economic burden is estimated at $34.4 billion per year, exceeding the combined costs of ovarian, breast, and colon cancers.
Black women experience fibroids two to three times more often than white women, with more severe symptoms linked to lower vitamin D levels caused by higher melanin.
Women often wait years before seeking treatment, but experts stress that early ultrasound screening and options like uterine myectomy can preserve fertility, urging patients to understand their bodies and demand multiple medical opinions.
Growing awareness and better self-advocacy are beginning to shift the conversation, offering hope that fibroids need not end a woman's reproductive journey.